David C. Sane

Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention

Steven R. Steinhubl, J. David Talley, Gregory A. Braden et al. · Circulation · 2001 · 358 citations

Statin Therapy May Be Associated With Lower Mortality in Patients With Diastolic Heart Failure

Hidekatsu Fukuta, David C. Sane, Steffen Brucks et al. · Circulation · 2005 · 293 citations · Full text

Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats

Andrew J. Sweatt, David C. Sane, S.M. Hutson et al. · Journal of Thrombosis and Haemostasis · 2003 · 163 citations

Mechanobiology, Developmental Biology, Bone Morphogenic Protein +12

Absence of Interaction Between Atorvastatin or Other Statins and Clopidogrel

Victor L. Serebruany, Mark Midei, Alex I. Malinin et al. · Archives of Internal Medicine · 2004 · 157 citations

Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization

Scott D. Berkowitz, David C. Sane, Kristina N. Sigmon et al. · Journal of the American College of Cardiology · 1998 · 155 citations

Thrombopoiesis, Percutaneous Coronary Intervention, Thrombosis +14